معرفی
Laura Cristina Alonso, M.D., is a Professor of Medicine at Weill Cornell Medical College and holds the E. Hugh Luckey Distinguished Professorship in Medicine. Board-certified in Endocrinology, Diabetes, and Metabolism, she specializes in diabetes care and metabolic disorders. Her research focuses on pancreatic beta-cell biology, insulin resistance mechanisms, and the intersection of diabetes with critical illness like COVID-19.
- M.D., University of Pennsylvania School of Medicine (1998)
- B.A., Harvard College (1993)
Her work spans beta-cell proliferation, metabolic programming, and NAD+ signaling in obesity-induced diabetes. Recent studies investigate telehealth applications, SARS-CoV-2's metabolic impacts, and circRNA analysis in pancreatic islets. She leads NIH-funded projects on ATF6 signaling and beta-cell dysfunction (2023-2030).
Dr. Alonso serves as Principal Investigator for NIDDK grants, exploring glucose metabolism, lipid dysregulation, and beta-cell regeneration. She has consulted for Eli Lilly, Sanofi, and Vertex Pharmaceuticals, contributing to pharmaceutical and medical device innovation.
